Seeka HY23: PBT halved and leverage climbs to 4.9x EBITDA on weak harvest

What changed

Revenue fell 14.0% to NZ$212.7m as kiwifruit harvest volumes were materially lower across the New Zealand industry. Operating leverage worked against Seeka: EBITDA dropped 26.2% to NZ$36.4m, PBT fell 54.6% to NZ$13.6m and NPAT fell 51.2% to NZ$10.5m. A lower effective tax rate (23.2% vs 28.6%) provided a mild cushion, so PBT is the cleaner read.

Segment mix tells a sharper story than the group print. Post-harvest operations remained the profit engine, holding an EBIT margin of roughly 24.5% on NZ$151.1m of revenue. Orchard operations swung from a NZ$3.7m profit to a NZ$3.1m loss, and Australian operations tipped from a NZ$1.6m profit to a small loss.

Cash deteriorated far faster than earnings. Net cash from operations collapsed 76.6% to NZ$4.5m, capex moderated to NZ$11.0m (from NZ$25.0m), and pre-lease FCF remained negative at roughly -NZ$6.5m. Gross borrowings rose to NZ$182.2m and cash fell to NZ$5.2m, lifting estimated net debt to NZ$177.0m and net debt/EBITDA to 4.9x from 3.3x.

What matters

• Leverage is the dominant read-through. Net debt/EBITDA of 4.9x on a trailing basis, combined with a sharply weaker operating cash flow, tightens the balance-sheet envelope going into second-half seasonality.
• Core economics held; ancillary operations broke. Post-harvest margins were resilient, so the earnings decline is largely a volume story in the dominant segment plus outright losses in orchards and Australia. That matters for how much of the HY23 weakness is cyclical (harvest volumes) versus structural (orchard economics at current pricing and cost base).
• Cash conversion deterioration is disproportionate. OCF/EBITDA fell from 38.8% to 12.3%. Even with trade receivable days improving to ~36.5 (from ~42.2) and inventory days easing, the operating cash shortfall suggests the working-capital tailwind was smaller than the earnings drop and other cash leakage.

Expectations

No quantified forward-work balance or numeric earnings target was provided in the extract, so run-rate checks against guidance are not possible. Historical shape is unhelpful here: HY22 accounted for 71% of FY22 revenue, 107% of FY22 EBITDA and 330% of FY22 NPAT — i.e. Seeka is heavily first-half weighted and FY22's second half was a loss-maker (-NZ$3.3m EBITDA, -NZ$15.0m NPAT implied). If the same shape recurs, HY23's NZ$10.5m NPAT should be read as close to the full-year outcome, not a building block for doubling up. Annualising HY23 revenue to NZ$425.3m overstates likely FY23 revenue for the same reason.

Quality of result

The earnings print is of mixed quality. There are no disclosed non-recurring items flattering the result, the tax rate move was modest, and post-harvest margins held — so the continuing core looks durable. Against that, cash backing is weak: pre-lease FCF was -NZ$6.5m despite a NZ$14.0m reduction in capex, and the NZ$10.5m NPAT was not supported by operating cash. ROE halved to 3.8% from 7.8%. The result is operationally coherent with a poor harvest, but it is not cash-generative at this volume level.

Unresolved

• Whether the orchard-segment loss and Australian-segment reversal reflect one-season volume shortfall or a re-based cost structure that persists into FY24.
• Banking headroom and covenant position at ~4.9x net debt/EBITDA, and whether the lift in current interest-bearing liabilities (to NZ$53.7m) signals a refinancing event in the next twelve months.
• The full bridge from EBITDA to operating cash flow: lease outflows, tax paid and detailed working-capital movements beyond receivables and inventory are not visible in the extract.
• Whether any earnings guidance range has been reiterated, narrowed or withdrawn for FY23.

This briefing cannot assess valuation, covenant terms, or management's current FY23 guidance because share price, covenant thresholds and a quantified forward target were not supplied.

Key metrics

Segment breakdown

Analytical metrics

---

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.